# Serum Visfatin and Serum Vaspin in Patients With Hepatocellular Carcinoma on Top of Liver Cirrhosis

> **NCT04763707** · — · COMPLETED · sponsor: **Sohag University** · enrollment: 87 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04763707
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2022-10-01
- **Final completion:** 2022-11-01
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2022-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04763707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04763707, "Serum Visfatin and Serum Vaspin in Patients With Hepatocellular Carcinoma on Top of Liver Cirrhosis". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT04763707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*